In cancer development, MDSCs accelerate tumor progression by inhibiting the T cell response and inducing regulatory T cells by releasing arginase 1 (Arg1), reactive oxygen species (ROS), and inducible nitric oxide synthase. Here, ARG1 is linked to neoplasm.